Oncology & Cancer

Common mutation is culprit in acute leukemia relapse

Harvard stem cell scientists have identified a mutation in human cases of acute lymphoblastic leukemia that likely drives relapse. The research, published in Cancer Cell, could translate into improved patient care strategies ...

Diseases, Conditions, Syndromes

A new way of improving tuberculosis treatment rejected

Tuberculosis kills 1.5 million people across the world every year. The existing treatment is effective but long. Many patients abandon it before completion, increasing the risk of a relapse and favouring the emergence of ...

Oncology & Cancer

Benefit of adjuvant dabrafenib, trametinib persists in melanoma

(HealthDay)—For patients with stage III melanoma with BRAF V600E or V600K mutations, 12 months of adjuvant dabrafenib plus trametinib results in increased survival without relapse or distant metastasis at five years, according ...

Neuroscience

Can hormone help treat multiple sclerosis long-term?

A new study suggests that treatment with adrenocorticotropic hormone (ACTH) may be helpful for people whose multiple sclerosis (MS) is not well-controlled through their regular treatment. The study was released today and ...

page 18 from 30